182 related articles for article (PubMed ID: 11675573)
41. Usefulness of lipids, lipoprotein(a) and fibrinogen measurements in identifying subjects at risk of occlusive complications following vascular and endovascular surgery.
Lippi G; Veraldi GF; Dorucci V; Dusi R; Ruzzenente O; Brentegani C; Guidi G; Cordiano C
Scand J Clin Lab Invest; 1998 Oct; 58(6):497-504. PubMed ID: 9832342
[TBL] [Abstract][Full Text] [Related]
42. Lipoprotein(a) and lipoprotein profile in healthy centenarians: a reappraisal of vascular risk factors.
Baggio G; Donazzan S; Monti D; Mari D; Martini S; Gabelli C; Dalla Vestra M; Previato L; Guido M; Pigozzo S; Cortella I; Crepaldi G; Franceschi C
FASEB J; 1998 Apr; 12(6):433-7. PubMed ID: 9535215
[TBL] [Abstract][Full Text] [Related]
43. Cytokine release and serum lipoprotein (a) alterations during hemodialysis.
Tzanatos HA; Agroyannis B; Chondros C; Kapetanaki A; Fourtounas C; Soubassi L; Kopelias I
Artif Organs; 2000 May; 24(5):329-33. PubMed ID: 10848673
[TBL] [Abstract][Full Text] [Related]
44. [The importance of lipoprotein(a) as a predictive factor of coronary atherosclerosis].
Mestre C; Grand A; Fournis Y; Mamelle N; Landrault E; Cambrillat N
Presse Med; 1998 May; 27(18):849-54. PubMed ID: 9767868
[TBL] [Abstract][Full Text] [Related]
45. Lipoprotein(a) in alcohol-dependent male patients during a six-month abstinence period.
Budzyński J; Kłopocka M; Swiatkowski M; Pulkowski G; Ziółkowski M
Alcohol Alcohol; 2003; 38(2):157-62. PubMed ID: 12634264
[TBL] [Abstract][Full Text] [Related]
46. Lipoprotein(a) serum levels in patients affected by chronic obstructive pulmonary disease.
Basili S; Ferroni P; Vieri M; Cardelli P; Ceci F; Paradiso M; Labbadia G; Gazzaniga PP; Cordova C; Alessandri C
Atherosclerosis; 1999 Dec; 147(2):249-52. PubMed ID: 10559510
[TBL] [Abstract][Full Text] [Related]
47. Plasma cholesterol and lipoprotein levels in relation to tumor aggressiveness and survival in HCC patients.
Carr BI; Giannelli G; Guerra V; Giannini EG; Farinati F; Rapaccini GL; Marco MD; Zoli M; Caturelli E; Masotto A; Virdone R; Sacco R; Trevisani F
Int J Biol Markers; 2018 Nov; 33(4):423-431. PubMed ID: 29874983
[TBL] [Abstract][Full Text] [Related]
48. The relationship between serum ferritin levels and serum lipids and HDL function with respect to age and gender.
Ellidag HY; Eren E; Akdag M; Giray O; Kiraz K; Yilmaz N
Ukr Biochem J; 2016; 88(6):76-86. PubMed ID: 29236376
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic value of serum ferritin in primary hepatocellular carcinoma.
Giannoulis E; Arvanitakis C; Nikopoulos A; Doutsos I; Tourkantonis A
Digestion; 1984; 30(4):236-41. PubMed ID: 6210220
[TBL] [Abstract][Full Text] [Related]
50. Hormonal regulation of serum lipoprotein (a) levels: effects of parenteral administration of estrogen or testosterone in males.
Berglund L; Carlström K; Stege R; Gottlieb C; Eriksson M; Angelin B; Henriksson P
J Clin Endocrinol Metab; 1996 Jul; 81(7):2633-7. PubMed ID: 8675589
[TBL] [Abstract][Full Text] [Related]
51. Serum ferritin level after resection of hepatocellular carcinoma. Correlation with alpha-fetoprotein level.
Nagasue N; Yukaya H; Chang YC; Ogawa Y
Cancer; 1986 May; 57(9):1820-3. PubMed ID: 2420438
[TBL] [Abstract][Full Text] [Related]
52. Effects of isotretinoin therapy on lipoprotein (a) serum levels.
Georgala S; Schulpis KH; Potouridou I; Papadogeorgaki H
Int J Dermatol; 1997 Nov; 36(11):863-4. PubMed ID: 9427083
[TBL] [Abstract][Full Text] [Related]
53. [Determination of lipoprotein (a) [Lp(a)] in patients with ischemic stroke. Preliminary communication].
Wehr H; Rodo M; Ryglewicz D; Mendel T; Bednarska-Makaruk M; Puławska M; Roszczynko M
Neurol Neurochir Pol; 2001; 35(1):35-40. PubMed ID: 11464714
[TBL] [Abstract][Full Text] [Related]
54. Marked effects of extreme levels of lipoprotein(a) on estimation of low-density lipoprotein cholesterol.
Saeedi R; Li M; Allard M; Frohlich J
Clin Biochem; 2014 Aug; 47(12):1098-9. PubMed ID: 24792456
[TBL] [Abstract][Full Text] [Related]
55. Thyroid hormone (fT4) reduces lipoprotein(a) plasma levels.
Hoppichler F; Sandholzer C; Moncayo R; Utermann G; Kraft HG
Atherosclerosis; 1995 May; 115(1):65-71. PubMed ID: 7669088
[TBL] [Abstract][Full Text] [Related]
56. [Effect of biliary obstruction on lipoprotein(a) concentration].
Calmarza P; Bajador E; Lapresta C; García Castañón S; de Castro I; Civeira F
Clin Investig Arterioscler; 2014; 26(5):218-23. PubMed ID: 24629889
[TBL] [Abstract][Full Text] [Related]
57. Effect of serum lipoprotein(a) on estimation of low-density lipoprotein cholesterol by the Friedewald formula.
Li KM; Wilcken DE; Dudman NP
Clin Chem; 1994 Apr; 40(4):571-3. PubMed ID: 8149612
[TBL] [Abstract][Full Text] [Related]
58. Lipoprotein(a) as a strong indicator for cerebrovascular disease.
Zenker G; Költringer P; Boné G; Niederkorn K; Pfeiffer K; Jürgens G
Stroke; 1986; 17(5):942-5. PubMed ID: 2945294
[TBL] [Abstract][Full Text] [Related]
59. Relation between circadian patterns in levels of circulating lipoprotein(a), fibrinogen, platelets, and related lipid variables in men.
Bremner WF; Sothern RB; Kanabrocki EL; Ryan M; McCormick JB; Dawson S; Connors ES; Rothschild R; Third JL; Vahed S; Nemchausky BM; Shirazi P; Olwin JH
Am Heart J; 2000 Jan; 139(1 Pt 1):164-73. PubMed ID: 10618578
[TBL] [Abstract][Full Text] [Related]
60. Lipoprotein(a) in patients with hepatocellular carcinoma and portal vein thrombosis.
Malaguarnera G; Catania VE; Francaviglia A; Malaguarnera M; Drago F; Motta M; Latteri S
Aging Clin Exp Res; 2017 Feb; 29(Suppl 1):185-190. PubMed ID: 27822883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
